BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism

References

• Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med 1999; 5:512 - 7; http://dx.doi.org/10.1038/8394; PMID: 10229227
   PubMed Web of Science ®Google Scholar
• Sedaghat AR, Siliciano JD, Brennan TP, Wilke CO, Siliciano RF. Limits on replenishment of the resting CD4+ T cell reservoir for HIV in patients on HAART. PLoS Pathog 2007; 3:e122; http://dx.doi.org/10.1371/journal.ppat.0030122; PMID: 17784786
   PubMed Web of Science ®Google Scholar
• Geeraert L, Kraus G, Pomerantz RJ. Hide-and-seek: the challenge of viral persistence in HIV-1 infection. Annu Rev Med 2008; 59:487 - 501; http://dx.doi.org/10.1146/annurev.med.59.062806.123001; PMID: 17845138
   PubMed Web of Science ®Google Scholar
• Williams SA, Chen LF, Kwon H, Fenard D, Bisgrove D, Verdin E, et al. Prostratin antagonizes HIV latency by activating NF-kappaB. J Biol Chem 2004; 279:42008 - 17; http://dx.doi.org/10.1074/jbc.M402124200; PMID: 15284245
   PubMed Web of Science ®Google Scholar
• Xing S, Bullen CK, Shroff NS, Shan L, Yang HC, Manucci JL, et al. Disulfiram reactivates latent HIV-1 in a Bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation. J Virol 2011; 85:6060 - 4; http://dx.doi.org/10.1128/JVI.02033-10; PMID: 21471244
   PubMed Web of Science ®Google Scholar
• Archin NM, Espeseth A, Parker D, Cheema M, Hazuda D, Margolis DM. Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid. AIDS Res Hum Retroviruses 2009; 25:207 - 12; http://dx.doi.org/10.1089/aid.2008.0191; PMID: 19239360
   PubMed Web of Science ®Google Scholar
• Contreras X, Schweneker M, Chen CS, McCune JM, Deeks SG, Martin J, et al. Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells. J Biol Chem 2009; 284:6782 - 9; http://dx.doi.org/10.1074/jbc.M807898200; PMID: 19136668
   PubMed Web of Science ®Google Scholar
• Edelstein LC, Micheva-Viteva S, Phelan BD, Dougherty JP. Short communication: activation of latent HIV type 1 gene expression by suberoylanilide hydroxamic acid (SAHA), an HDAC inhibitor approved for use to treat cutaneous T cell lymphoma. AIDS Res Hum Retroviruses 2009; 25:883 - 7; http://dx.doi.org/10.1089/aid.2008.0294; PMID: 19689202
   PubMed Web of Science ®Google Scholar
• Van Lint C, Emiliani S, Ott M, Verdin E. Transcriptional activation of the HIV-1 promoter in response to histone acetylation.. EMBO J 1996; 15:1112 - 20; PMID: 8605881
   PubMed Web of Science ®Google Scholar
• Quivy V, Adam E, Collette Y, Demonte D, Chariot A, Vanhulle C, et al. Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies. J Virol 2002; 76:11091 - 103; http://dx.doi.org/10.1128/JVI.76.21.11091-11103.2002; PMID: 12368351
   PubMed Web of Science ®Google Scholar
• Nicodeme E, Jeffery KI, Schaefer U, Beinke S, Dewell S, Chung CW, et al. Suppression of inflammation by a synthetic histone mimic.. Nature 2010; 468:1119 - 23; http://dx.doi.org/10.1038/nature09589; PMID: 21068722
   PubMed Web of Science ®Google Scholar
• Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, Fedorov O, et al. Selective inhibition of BET bromodomains. Nature 2010; 468:1067 - 73; http://dx.doi.org/10.1038/nature09504; PMID: 20871596
   PubMed Web of Science ®Google Scholar
• Dawson MA, Prinjha RK, Dittmann A, Giotopoulos G, Bantscheff M, Chan WI, et al. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature 2011; 478:529 - 33; http://dx.doi.org/10.1038/nature10509; PMID: 21964340
   PubMed Web of Science ®Google Scholar
• Wu SY, Chiang CM. The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation. J Biol Chem 2007; 282:13141 - 5; http://dx.doi.org/10.1074/jbc.R700001200; PMID: 17329240
   PubMed Web of Science ®Google Scholar
• Yang Z, Yik JH, Chen R, He N, Jang MK, Ozato K, et al. Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Mol Cell 2005; 19:535 - 45; http://dx.doi.org/10.1016/j.molcel.2005.06.029; PMID: 16109377
   PubMed Web of Science ®Google Scholar
• Jang MK, Mochizuki K, Zhou M, Jeong HS, Brady JN, Ozato K. The bromodomain protein BRD4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transactivation.. Mol Cell 2005; 19:523 - 34; PMID: 16109376
   PubMed Web of Science ®Google Scholar
• Zhu Y, Pe'ery T, Peng J, Ramanathan Y, Marshall N, Marshall T, et al. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro.. Genes Dev 1997; 11:2622 - 32; http://dx.doi.org/10.1101/gad.11.20.2622; PMID: 9334325
   PubMed Web of Science ®Google Scholar
• Peterlin BM, Price DH. Controlling the elongation phase of transcription with P-TEFb. Mol Cell 2006; 23:297 - 305; http://dx.doi.org/10.1016/j.molcel.2006.06.014; PMID: 16885020
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y, Takagi T, Wada T, Yano K, Furuya A, Sugimoto S, et al. NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell 1999; 97:41 - 51; http://dx.doi.org/10.1016/S0092-8674(00)80713-8; PMID: 10199401
   PubMed Web of Science ®Google Scholar
• Wada T, Takagi T, Yamaguchi Y, Ferdous A, Imai T, Hirose S, et al. DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes Dev 1998; 12:343 - 56; http://dx.doi.org/10.1101/gad.12.3.343; PMID: 9450929
   PubMed Web of Science ®Google Scholar
• Wada T, Takagi T, Yamaguchi Y, Watanabe D, Handa H. Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro. EMBO J 1998; 17:7395 - 403; http://dx.doi.org/10.1093/emboj/17.24.7395; PMID: 9857195
   PubMed Web of Science ®Google Scholar
• Price DH. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol Cell Biol 2000; 20:2629 - 34; http://dx.doi.org/10.1128/MCB.20.8.2629-2634.2000; PMID: 10733565
   PubMed Web of Science ®Google Scholar
• Wei P, Garber ME, Fang SM, Fischer WH, Jones KA. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 1998; 92:451 - 62; http://dx.doi.org/10.1016/S0092-8674(00)80939-3; PMID: 9491887
   PubMed Web of Science ®Google Scholar
• Mueller D, Bach C, Zeisig D, Garcia-Cuellar MP, Monroe S, Sreekumar A, et al. A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification. Blood 2007; 110:4445 - 4454; http://dx.doi.org/10.1182/blood-2007-05-090514; PMID: 17855633
   PubMed Web of Science ®Google Scholar
• Yik JH, Chen R, Jennings JL, Link AJ, Zhou Q. Inhibition of p_TEFb (CDK9/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA. Mol Cell 2003; 12:971 - 82; PMID: 14580347
   PubMed Web of Science ®Google Scholar
• Michels AA, Fraldi A, Li Q, Adamson TE, Bonnet F, Nguyen VT, et al. Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitor. EMBO J 2004; 23:2608 - 19; http://dx.doi.org/10.1038/sj.emboj.7600275; PMID: 15201869
   PubMed Web of Science ®Google Scholar
• Bisgrove DA, Mahmoudi T, Henklein P, Verdin E. Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription. Proc Natl Acad Sci USA 2007; 104:13690 - 5; http://dx.doi.org/10.1073/pnas.0705053104; PMID: 17690245
   PubMed Web of Science ®Google Scholar
• Bisgrove D, Lewinski M, Bushman F, Verdin E. Molecular mechanisms of HIV-1 proviral latency. Expert Rev Anti Infect Ther 2005; 3:805 - 14; http://dx.doi.org/10.1586/14787210.3.5.805; PMID: 16207172
   PubMedGoogle Scholar
• Fu J, Yoon HG, Qin J, Wong J. Regulation of P-TEFb Elongation Complex Activity by CDK9 Acetylation. Mol Cell Biol 2007; 27:4641 - 51; http://dx.doi.org/10.1128/MCB.00857-06
   PubMed Web of Science ®Google Scholar
• Cho S, Schroeder S, Kaehlcke K, Kwon HS, Pedal A, Herker E, et al. Acetylation of cyclin T1 regulates the equilibrium between active and inactive P-TEFb in cells. EMBO J 2009; 28:1407 - 17; http://dx.doi.org/10.1038/emboj.2009.99; PMID: 19387490
   PubMed Web of Science ®Google Scholar
• Ott M, Schnölzer M, Garnica J, Fischle W, Emiliani S, Rackwitz HR, et al. Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity. Curr Biol 1999; 9:1489 - 92; http://dx.doi.org/10.1016/S0960-9822(00)80120-7; PMID: 10607594
   PubMed Web of Science ®Google Scholar
• Kiernan RE, Vanhulle C, Schiltz L, Adam E, Xiao H, Maudoux F, et al. HIV-1 tat transcriptional activity is regulated by acetylation. EMBO J 1999; 18:6106 - 18; http://dx.doi.org/10.1093/emboj/18.21.6106; PMID: 10545121
   PubMed Web of Science ®Google Scholar
• Dorr A, Kiermer V, Pedal A, Rackwitz HR, Henklein P, Schubert U, et al. Transcriptional synergy between Tat and PCAF is dependent on the binding of acetylated Tat to the PCAF bromodomain. EMBO J 2002; 21:2715 - 23; http://dx.doi.org/10.1093/emboj/21.11.2715; PMID: 12032084
   PubMed Web of Science ®Google Scholar
• Mujtaba S, He Y, Zeng L, Farooq A, Carlson JE, Ott M, et al. Structural basis of lysine-acetylated HIV-1 Tat recognition by PCAF bromodomain. Mol Cell 2002; 9:575 - 86; http://dx.doi.org/10.1016/S1097-2765(02)00483-5; PMID: 11931765
   PubMed Web of Science ®Google Scholar
• Kaehlcke K, Dorr A, Hetzer-Egger C, Kiermer V, Henklein P, Schnoelzer M, et al. Acetylation of Tat defines a cyclinT1-independent step in HIV transactivation. Mol Cell 2003; 12:167 - 76; http://dx.doi.org/10.1016/S1097-2765(03)00245-4; PMID: 12887902
   PubMed Web of Science ®Google Scholar
• Schröder S, Cho S, Zeng L, Zhang Q, Kaehlcke K, Mak L, et al. Two-pronged binding with bromodomain-containing protein 4 liberates positive transcription elongation factor b from inactive ribonucleoprotein complexes. J Biol Chem 2012; 287:1090 - 9; http://dx.doi.org/10.1074/jbc.M111.282855; PMID: 22084242
   PubMed Web of Science ®Google Scholar
• Nicodeme E, Jeffrey KL, Schaefer U, Beinke S, Dewell S, Chung CW, et al. Suppression of inflammation by a synthetic histone mimic. Nature 2010; 468:1119 - 23; http://dx.doi.org/10.1038/nature09589; PMID: 21068722
   PubMed Web of Science ®Google Scholar
• Zhang G, Liu R, Zhong Y, Plotnikov AN, Zhang W, Zeng L, et al. Down-regulation of NF-κB transcriptional activity in HIV-associated kidney disease by BRD4 inhibition. J Biol Chem 2012; 287:28840 - 51; http://dx.doi.org/10.1074/jbc.M112.359505; PMID: 22645123
   PubMed Web of Science ®Google Scholar
• Banerjee C, Archin N, Michaels D, Belkina AC, Denis GV, Bradner J, et al. BET bromodomain inhibition as a novel strategy for reactivation of HIV-1. J Leukoc Biol 2012; 92:1147 - 54; http://dx.doi.org/10.1189/jlb.0312165; PMID: 22802445
   PubMed Web of Science ®Google Scholar
• Ott CJ, Kopp N, Bird L, Paranal RM, Qi J, Bowman T, et al. BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia. Blood 2012; 120:2843 - 52; http://dx.doi.org/10.1182/blood-2012-02-413021; PMID: 22904298
   PubMed Web of Science ®Google Scholar
• Bartholomeeusen K, Xiang Y, Fujinaga K, Peterlin BM. Bromodomain and extra-terminal (BET) bromodomain inhibition activate transcription via transient release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein. J Biol Chem 2012; 287:36609 - 16; http://dx.doi.org/10.1074/jbc.M112.410746; PMID: 22952229
   PubMed Web of Science ®Google Scholar
• Li Z, Guo J, Wu Y, Zhou Q. The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation. Nucleic Acids Res 2013; 41:277 - 87; http://dx.doi.org/10.1093/nar/gks976; PMID: 23087374
   PubMed Web of Science ®Google Scholar
• Zhu J, Gaiha GD, John SP, Pertel T, Chin CR, Gao G, et al. Reactivation of latent HIV-1 by inhibition of BRD4. Cell Rep 2012; 2:807 - 16; http://dx.doi.org/10.1016/j.celrep.2012.09.008; PMID: 23041316
   PubMed Web of Science ®Google Scholar
• Jordan A, Bisgrove D, Verdin E. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J 2003; 22:1868 - 77; http://dx.doi.org/10.1093/emboj/cdg188; PMID: 12682019
   PubMed Web of Science ®Google Scholar
• Kutsch O, Benveniste EN, Shaw GM, Levy DN. Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency. J Virol 2002; 76:8776 - 86; http://dx.doi.org/10.1128/JVI.76.17.8776-8786.2002; PMID: 12163598
   PubMed Web of Science ®Google Scholar
• Xing S, Bhat S, Shroff NS, Zhang H, Lopez JA, Margolick JB, et al. Novel structurally related compounds reactivate latent HIV-1 in a bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation. J Antimicrob Chemother 2012; 67:398 - 403; http://dx.doi.org/10.1093/jac/dkr496; PMID: 22160146
   PubMed Web of Science ®Google Scholar
• Yang HC, Xing S, Shan L, O’Connell K, Dinoso J, Shen A, et al. Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation. J Clin Invest 2009; 119:3473 - 86; PMID: 19805909
   PubMed Web of Science ®Google Scholar
• Shan L, Deng K, Shroff NS, Durand CM, Rabi SA, Yang HC, et al. Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. Immunity 2012; 36:491 - 501; http://dx.doi.org/10.1016/j.immuni.2012.01.014; PMID: 22406268
   PubMed Web of Science ®Google Scholar
• Bosque A, Planelles V. Studies of HIV-1 latency in an ex vivo model that uses primary central memory T cells. Methods 2011; 53:54 - 61; http://dx.doi.org/10.1016/j.ymeth.2010.10.002; PMID: 20970502
   PubMed Web of Science ®Google Scholar
• Bosque A, Planelles V. Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells. Blood 2009; 113:58 - 65; http://dx.doi.org/10.1182/blood-2008-07-168393; PMID: 18849485
   PubMed Web of Science ®Google Scholar
• Dar RD, Razooky BS, Singh A, Trimeloni TV, McCollum JM, Cox CD, et al. Transcriptional burst frequency and burst size are equally modulated across the human genome. Proc Natl Acad Sci USA 2012; 109:17454 - 9; http://dx.doi.org/10.1073/pnas.1213530109; PMID: 23064634
   PubMed Web of Science ®Google Scholar
• Kepler TB, Elston TC. Stochasticity in transcriptional regulation: origins, consequences, and mathematical representations. Biophys J 2001; 81:3116 - 36; http://dx.doi.org/10.1016/S0006-3495(01)75949-8; PMID: 11720979
   PubMed Web of Science ®Google Scholar
• Simpson ML, Cox CD, Sayler GS. Frequency domain chemical Langevin analysis of stochasticity in gene transcriptional regulation. J Theor Biol 2004; 229:383 - 94; http://dx.doi.org/10.1016/j.jtbi.2004.04.017; PMID: 15234205
   PubMed Web of Science ®Google Scholar
• Singh A, Razooky B, Cox CD, Simpson ML, Weinberger LS. Transcriptional bursting from the HIV-1 promoter is a significant source of stochastic noise in HIV-1 gene expression. Biophys J 2010; 98:L32 - 4; http://dx.doi.org/10.1016/j.bpj.2010.03.001; PMID: 20409455
   PubMed Web of Science ®Google Scholar
• Malovannaya A, Lanz RB, Jung SY, Bulynko Y, Le NT, Chan DW, et al. Analysis of the human endogenous coregulator complexome. Cell 2011; 145:787 - 99; http://dx.doi.org/10.1016/j.cell.2011.05.006; PMID: 21620140
   PubMed Web of Science ®Google Scholar
• Antoni BA, Rabson AB, Kinter A, Bodkin M, Poli G. NF-kappa B-dependent and -independent pathways of HIV activation in a chronically infected T cell line. Virology 1994; 202:684 - 94; http://dx.doi.org/10.1006/viro.1994.1390; PMID: 7913275
   PubMed Web of Science ®Google Scholar
• Folks TM, Justement J, Kinter A, Dinarello CA, Fauci AS. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 1987; 238:800 - 2; http://dx.doi.org/10.1126/science.3313729; PMID: 3313729
   PubMed Web of Science ®Google Scholar
• Han Y, Wind-Rotolo M, Yang HC, Siliciano JD, Siliciano RF. Experimental approaches to the study of HIV-1 latency. Nat Rev Microbiol 2007; 5:95 - 106; http://dx.doi.org/10.1038/nrmicro1580; PMID: 17224919
   PubMed Web of Science ®Google Scholar
• Denis GV, McComb ME, Faller DV, Sinha A, Romesser PB, Costello CE. Identification of transcription complexes that contain the double bromodomain protein Brd2 and chromatin remodeling machines. J Proteome Res 2006; 5:502 - 11; http://dx.doi.org/10.1021/pr050430u; PMID: 16512664
   PubMed Web of Science ®Google Scholar
• Denis GV, Vaziri C, Guo N, Faller DV. RING3 kinase transactivates promoters of cell cycle regulatory genes through E2F. Cell Growth Differ 2000; 11:417 - 24; PMID: 10965846
   PubMedGoogle Scholar
• LeRoy G, Rickards B, Flint SJ. The double bromodomain proteins Brd2 and Brd3 couple histone acetylation to transcription. Mol Cell 2008; 30:51 - 60; http://dx.doi.org/10.1016/j.molcel.2008.01.018; PMID: 18406326
   PubMed Web of Science ®Google Scholar
• Sinha A, Faller DV, Denis GV. Bromodomain analysis of Brd2-dependent transcriptional activation of cyclin A. Biochem J 2005; 387:257 - 69; http://dx.doi.org/10.1042/BJ20041793; PMID: 15548137
   PubMed Web of Science ®Google Scholar
• Peng J, Dong W, Chen L, Zou T, Qi Y, Liu Y. Brd2 is a TBP-associated protein and recruits TBP into E2F-1 transcriptional complex in response to serum stimulation. Mol Cell Biochem 2007; 294:45 - 54; http://dx.doi.org/10.1007/s11010-006-9223-6; PMID: 17111193
   PubMed Web of Science ®Google Scholar
• Benevolenskaya EV, Murray HL, Branton P, Young RA, Kaelin WG Jr.. Binding of pRB to the PHD protein RBP2 promotes cellular differentiation. Mol Cell 2005; 18:623 - 35; http://dx.doi.org/10.1016/j.molcel.2005.05.012; PMID: 15949438
   PubMed Web of Science ®Google Scholar
• Jiang YW, Veschambre P, Erdjument-Bromage H, Tempst P, Conaway JW, Conaway RC, et al. Mammalian mediator of transcriptional regulation and its possible role as an end-point of signal transduction pathways. Proc Natl Acad Sci USA 1998; 95:8538 - 43; http://dx.doi.org/10.1073/pnas.95.15.8538; PMID: 9671713
   PubMed Web of Science ®Google Scholar
• Kuras L, Borggrefe T, Kornberg RD. Association of the Mediator complex with enhancers of active genes. Proc Natl Acad Sci USA 2003; 100:13887 - 91; http://dx.doi.org/10.1073/pnas.2036346100; PMID: 14623974
   PubMed Web of Science ®Google Scholar
• Kornberg RD. Mediator and the mechanism of transcriptional activation. Trends Biochem Sci 2005; 30:235 - 9; http://dx.doi.org/10.1016/j.tibs.2005.03.011; PMID: 15896740
   PubMed Web of Science ®Google Scholar
• Belkina AC, Denis GV. BET domain co-regulators in obesity, inflammation and cancer. Nat Rev Cancer 2012; 12:465 - 77; http://dx.doi.org/10.1038/nrc3256; PMID: 22722403
   PubMed Web of Science ®Google Scholar
• Naldini L, Blömer U, Gallay P, Ory D, Mulligan R, Gage FH, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272:263 - 7; http://dx.doi.org/10.1126/science.272.5259.263; PMID: 8602510
   PubMed Web of Science ®Google Scholar
• Weinberger LS, Burnett JC, Toettcher JE, Arkin AP, Schaffer DV. Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity. Cell 2005; 122:169 - 82; http://dx.doi.org/10.1016/j.cell.2005.06.006; PMID: 16051143
   PubMed Web of Science ®Google Scholar
• Weinberger LS, Shenk T. An HIV feedback resistor: auto-regulatory circuit deactivator and noise buffer. PLoS Biol 2007; 5:e9; http://dx.doi.org/10.1371/journal.pbio.0050009; PMID: 17194214
   PubMed Web of Science ®Google Scholar
• Weinberger LS, Dar RD, Simpson ML. Transient-mediated fate determination in a transcriptional circuit of HIV. Nat Genet 2008; 40:466 - 70; http://dx.doi.org/10.1038/ng.116; PMID: 18344999
   PubMed Web of Science ®Google Scholar
• Austin DW, Allen MS, McCollum JM, Dar RD, Wilgus JR, Sayler GS, et al. Gene network shaping of inherent noise spectra. Nature 2006; 439:608 - 11; http://dx.doi.org/10.1038/nature04194; PMID: 16452980
   PubMed Web of Science ®Google Scholar
• Cox CD, McCollum JM, Allen MS, Dar RD, Simpson ML. Using noise to probe and characterize gene circuits. Proc Natl Acad Sci USA 2008; 105:10809 - 14; http://dx.doi.org/10.1073/pnas.0804829105; PMID: 18669661
   PubMed Web of Science ®Google Scholar